Antiarrhythmic Drugs
CLASS I – Sodium Channel Blockers
|
Drug & Class |
Mechanism of Action + Uses |
Side Effects + Contraindications |
|
Procainamide (Class IA) |
Moderate Na⁺ block + K⁺ block → ↑ APD & ↑ QT. Uses: Stable monomorphic VT, pre-excited AF (WPW + AF), SVT with aberrancy |
QT prolongation → torsades, hypotension (IV), drug-induced lupus, agranulocytosis. Avoid in prolonged QT, severe LV dysfunction |
|
Quinidine (Class IA) |
Na⁺ + K⁺ block → slows conduction, ↑ QT. Uses: Rare in ICU; AF cardioversion (historical) |
Torsades, cinchonism (tinnitus, headache), thrombocytopenia. Avoid in QT prolongation |
|
Disopyramide (Class IA) |
Na⁺ block + anticholinergic effect. Uses: Hypertrophic obstructive cardiomyopathy (HOCM) |
Strong negative inotrope → HF worsening, urinary retention, glaucoma, torsades |
|
Lidocaine (Class IB) |
Weak Na⁺ block; acts on ischemic ventricular tissue; ↓ APD. Uses: Ischemic VT, VF (post-MI), refractory VF |
CNS toxicity (seizures, confusion), hypotension. Avoid in severe AV block without pacemaker |
|
Mexiletine (Class IB) |
Oral lidocaine analogue. Uses: Chronic ventricular arrhythmias |
GI upset, tremor, CNS toxicity |
|
Flecainide (Class IC) |
Strong Na⁺ block → marked conduction slowing. Uses: Paroxysmal AF (no structural heart disease) |
Proarrhythmia, QRS widening, ↑ mortality post-MI (CAST trial). ❌ Contraindicated in structural heart disease |
|
Propafenone (Class IC) |
Na⁺ block + weak β-blockade. Uses: Pill-in-pocket AF (selected patients) |
Metallic taste, bradycardia, proarrhythmia. Avoid in LV dysfunction |
CLASS II – Beta Blockers
|
Drug & Class |
Mechanism + Uses |
Side Effects + Contraindications |
|
Metoprolol (Class II) |
Uses: AF with RVR, post-MI arrhythmia, electrical storm |
Bradycardia, hypotension, bronchospasm. Avoid in severe asthma, decompensated HF |
|
Esmolol (Class II) |
Uses: ICU rate control, peri-intubation tachycardia, electrical storm |
Hypotension, bradycardia. Avoid in AV block |
|
Propranolol (Class II) |
Uses: Thyroid storm arrhythmias, long QT |
Bronchospasm, hypoglycemia masking |
CLASS III – Potassium Channel Blockers
|
Drug & Class |
Mechanism + Uses |
Side Effects + Contraindications |
|
Amiodarone (Class III, multi-channel) |
Blocks Na, K, Ca + β-block Uses: Stable VT, VF/pVT (ACLS), AF in structural heart disease, electrical storm |
Pulmonary fibrosis, thyroid dysfunction (hypo/hyper), hepatotoxicity, corneal deposits, photosensitivity, bradycardia |
|
Sotalol (Class III + β block) |
Uses: AF, VT prevention |
High torsades risk, renal dose adjustment required |
|
Dofetilide (Pure Class III) |
K⁺ channel block → ↑ QT. Uses: AF maintenance |
Torsades, requires inpatient initiation |
|
Ibutilide (Class III) |
↑ slow inward Na current → ↑ APD. Uses: Acute AF/flutter cardioversion |
High torsades risk → give Mg prophylactically |
CLASS IV – Calcium Channel Blockers
|
Drug & Class |
Mechanism + Uses |
Side Effects + Contraindications |
|
Diltiazem (Class IV) |
L-type Ca block → ↓ AV conduction. Uses: AF with RVR (stable) |
Hypotension, bradycardia. Avoid in HFrEF, WPW + AF |
|
Verapamil (Class IV) |
Uses: SVT, AF rate control |
Severe hypotension, heart block. Avoid in LV dysfunction |
OTHER IMPORTANT ICU ANTIARRHYTHMICS
|
Drug |
Mechanism + Uses |
Side Effects + Contraindications |
|
Adenosine |
Transient AV nodal block. Uses: PSVT, diagnostic for narrow complex tachycardia |
Flushing, chest pain, transient asystole. ❌ Avoid in asthma, irregular wide complex tachycardia |
|
Magnesium sulfate |
Stabilizes myocardium; suppresses early afterdepolarizations. Uses: Torsades de pointes, long QT |
Flushing, hypotension in rapid infusion |
|
Digoxin |
↑ Vagal tone → ↓ AV conduction. Uses: AF in HFrEF, hypotensive AF |
Toxicity: arrhythmias, visual changes, hyperkalemia. Avoid in WPW + AF |
CRITICAL ICU CONTRAINDICATION TABLE
|
Situation |
Absolutely Avoid |
|
WPW + AF |
Beta blocker, Diltiazem, Verapamil, Digoxin, Adenosine |
|
Structural heart disease |
Class IC drugs |
|
Long QT |
Class IA, Class III |
|
Decompensated HFrEF |
Verapamil, Diltiazem |
Drug of Choice Table
VENTRICULAR TACHYCARDIA (VT)
1. Monomorphic VT (Regular Wide Complex)
|
Scenario |
Drug of Choice |
|
Stable monomorphic VT (structural heart disease) |
Amiodarone |
|
Stable monomorphic VT (no severe LV dysfunction) |
Procainamide (often superior efficacy) |
|
Ischemic VT (post-MI) |
Lidocaine |
|
Recurrent VT |
Amiodarone infusion ± Beta blocker |
|
Scar-related VT |
Amiodarone |
2. Polymorphic VT (Normal QT)
|
Scenario |
Drug of Choice |
|
Stable polymorphic VT (normal QT) |
Amiodarone |
3. Torsades de Pointes (Polymorphic VT with Long QT)
|
Scenario |
Drug of Choice |
|
Torsades (any Mg level) |
Magnesium sulfate IV (2 g) |
|
Bradycardia-induced torsades |
Isoproterenol or temporary pacing |
|
Drug-induced QT prolongation |
Stop offending drug + Mg |
4. Electrical Storm
(≥3 VT/VF episodes in 24 hrs)
|
Scenario |
Drug of Choice |
|
Electrical storm (structural heart disease) |
Amiodarone + Beta blocker (Esmolol/Metoprolol) |
|
Refractory |
Add Lidocaine |
|
Ischemic trigger |
Urgent revascularization |
|
Sympathetic surge |
Deep sedation ± Stellate ganglion block |
SUPRAVENTRICULAR TACHYCARDIA (SVT)
1. AVNRT (Most Common SVT)
|
Scenario |
Drug of Choice |
|
Stable AVNRT |
Adenosine |
|
If adenosine contraindicated |
Diltiazem or Verapamil |
|
Recurrent |
Beta blocker |
2. AVRT (WPW Syndrome)
Orthodromic AVRT (Narrow Complex)
|
Scenario |
Drug of Choice |
|
Stable |
Adenosine |
|
Recurrent |
Beta blocker |
3.Antidromic AVRT (Wide Complex)
|
Scenario |
Drug of Choice |
|
Stable |
Procainamide |
|
Avoid |
AV nodal blockers |
4. Atrial Fibrillation (AF)
|
Scenario |
Drug of Choice |
|
AF with RVR (stable, no HFrEF) |
Diltiazem or Beta blocker |
|
AF with RVR + HFrEF |
Amiodarone or Digoxin |
|
AF < 48 hrs (rhythm control) |
Amiodarone |
|
AF > 48 hrs |
Rate control + anticoagulation |
|
AF + WPW (pre-excited AF) |
Procainamide |
5. Atrial Flutter
|
Scenario |
Drug of Choice |
|
Stable rate control |
Diltiazem / Beta blocker |
|
Rhythm conversion |
Ibutilide or Amiodarone |
6. Multifocal Atrial Tachycardia (MAT)
|
Scenario |
Drug of Choice |
|
MAT (COPD patient) |
Treat underlying + Magnesium |
|
Rate control |
Verapamil |
